Antibody recognizing folate receptors alpha and beta
US-2015343088-A1 · Dec 3, 2015 · US
Methods for treating tourniquet-induced injuries
US9006180B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9006180-B2 |
| Application number | US-201314088097-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 22, 2013 |
| Priority date | Aug 1, 2008 |
| Publication date | Apr 14, 2015 |
| Grant date | Apr 14, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating an injury to a mammal, comprising administering to the mammal a composition comprising flagellin, wherein the injury is tourniquet-induced injury to a limb of the mammal, and wherein the flagellin comprises the sequence of SEQ ID NO: 8. 2. The method of claim 1 , wherein the tourniquet-induced injury is associated with reperfusion. 3. The method of claim 1 , wherein the tourniquet-induc…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K38/164Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9006180B2 cover?
- The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin.
- Who is the assignee on this patent?
- Cleveland Biolabs Inc, Cleveland Clinic Foundation
- What technology area does this patent fall under?
- Primary CPC classification A61K38/164. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).